Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions.

Saved in:
Bibliographic Details
Title: Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions.
Authors: Damelin M; Pfizer, Inc., Pearl River, New York. scott.dylla@stemcentrx.com marc.damelin@pfizer.com., Bankovich A; Stemcentrx, Inc., South San Francisco, California., Park A; Stemcentrx, Inc., South San Francisco, California., Aguilar J; Stemcentrx, Inc., South San Francisco, California., Anderson W; Stemcentrx, Inc., South San Francisco, California., Santaguida M; Stemcentrx, Inc., South San Francisco, California., Aujay M; Stemcentrx, Inc., South San Francisco, California., Fong S; Stemcentrx, Inc., South San Francisco, California., Khandke K; Pfizer, Inc., Pearl River, New York., Pulito V; Pfizer, Inc., Pearl River, New York., Ernstoff E; Pfizer, Inc., Pearl River, New York., Escarpe P; Stemcentrx, Inc., South San Francisco, California., Bernstein J; Stemcentrx, Inc., South San Francisco, California., Pysz M; Stemcentrx, Inc., South San Francisco, California., Zhong W; Pfizer, Inc., Pearl River, New York., Upeslacis E; Pfizer, Inc., Pearl River, New York., Lucas J; Pfizer, Inc., Pearl River, New York., Lucas J; Pfizer, Inc., Pearl River, New York., Nichols T; Pfizer, Inc., Pearl River, New York., Loving K; Stemcentrx, Inc., South San Francisco, California., Foord O; Stemcentrx, Inc., South San Francisco, California., Hampl J; Stemcentrx, Inc., South San Francisco, California., Stull R; Stemcentrx, Inc., South San Francisco, California., Barletta F; Pfizer, Inc., Pearl River, New York., Falahatpisheh H; Pfizer, Inc., Pearl River, New York., Sapra P; Pfizer, Inc., Pearl River, New York., Gerber HP; Pfizer, Inc., Pearl River, New York., Dylla SJ; Stemcentrx, Inc., South San Francisco, California. scott.dylla@stemcentrx.com marc.damelin@pfizer.com.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Sep 15; Vol. 21 (18), pp. 4165-73. Date of Electronic Publication: 2015 May 26.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-15-0695